• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化心肌病在肝移植时代:精确逐步评估的时机。

Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation.

机构信息

Cardiology Department, Carol Davila University of Medicine, Bucharest; Gastroenterology Department, University Emergency Hospital, Bucharest, Romania.

Cardiology Department, Carol Davila University of Medicine, Bucharest; Gastroenterology Department, Colentina Clinical Hospital, Bucharest, Romania.

出版信息

J Gastrointestin Liver Dis. 2020 Dec 13;29(4):665-675. doi: 10.15403/jgld-3137.

DOI:10.15403/jgld-3137
PMID:33331343
Abstract

Liver cirrhosis (LC) is an important cause of mortality. Access to liver transplantation (LT) has significantly improved the prognosis of LC. A rigorous pre-transplant cardiac evaluation is mandatory, since cardiac dysfunction is considered the main cause of mortality after LT. Notwithstanding, the most updated pre-LT evaluation guidelines provide only an algorithm for the evaluation of major cardiovascular diseases, with no specific recommendations concerning cirrhotic cardiomyopathy (CCM), which is linked to various complications in LC, especially the development of heart failure after invasive procedures and surgical interventions, including LT. CCM is characterized by a cardiac dysfunction that includes systolic and/or diastolic dysfunction and/or electrophysiological abnormalities, in the absence of other known cardiac diseases. The role of the novel methods, tissue Doppler imaging and speckle tracking echocardiography, might be essential in the early detection of cardiac dysfunction, with prognosis implications in LC. All these new methods were only recently included in the CCM diagnosis algorithm. This review summarizes the old and novel techniques used for the diagnosis of CCM, with their diagnosis and prognostic role. It also highlights the strengths and the weaknesses of the new provided CCM diagnostic consensus, and proposes a step-by- step novel diagnostic algorithm, in order to better detect cardiac dysfunction.cirrhotic cardiomyopathy.

摘要

肝硬化(LC)是一种重要的死亡原因。接受肝移植(LT)显著改善了 LC 的预后。严格的移植前心脏评估是强制性的,因为心脏功能障碍被认为是 LT 后死亡的主要原因。尽管如此,最新的 LT 前评估指南仅提供了一种评估主要心血管疾病的算法,而对于与 LC 的各种并发症相关的肝硬化心肌病(CCM)没有具体的建议,特别是在侵入性程序和手术干预后发生心力衰竭,包括 LT。CCM 的特征是心脏功能障碍,包括收缩和/或舒张功能障碍和/或电生理异常,而没有其他已知的心脏病。新型方法,组织多普勒成像和斑点追踪超声心动图的作用可能对于早期检测心脏功能障碍至关重要,这对 LC 的预后有影响。所有这些新方法最近才被纳入 CCM 诊断算法。本综述总结了用于诊断 CCM 的旧的和新的技术,及其诊断和预后作用。它还强调了新的 CCM 诊断共识的优缺点,并提出了一个逐步的新的诊断算法,以更好地检测心脏功能障碍。

相似文献

1
Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation.肝硬化心肌病在肝移植时代:精确逐步评估的时机。
J Gastrointestin Liver Dis. 2020 Dec 13;29(4):665-675. doi: 10.15403/jgld-3137.
2
Cirrhotic Cardiomyopathy-A Veiled Threat.肝硬化性心肌病——隐匿的威胁。
Cardiol Rev. 2022;30(2):80-89. doi: 10.1097/CRD.0000000000000377.
3
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.肝硬化性心肌病:发病机制与临床相关性。
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):177-86. doi: 10.1038/nrgastro.2013.210. Epub 2013 Nov 12.
4
Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander.移植后肝硬化性心肌病:既非短暂亦非无辜旁观者。
Hepatology. 2018 Nov;68(5):2008-2015. doi: 10.1002/hep.30040. Epub 2018 Oct 13.
5
An update on cirrhotic cardiomyopathy.肝硬化性心肌病研究进展。
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):497-505. doi: 10.1080/17474124.2019.1587293. Epub 2019 Mar 8.
6
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.肝移植前后阶段的肝硬化性心肌病
J Cardiol. 2016 Feb;67(2):125-30. doi: 10.1016/j.jjcc.2015.04.016. Epub 2015 Jun 11.
7
Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?肝硬化性心肌病:肝脏与心肌的相互作用。当肝脏出现疾病时,心血管系统会如何反应?
Curr Cardiol Rev. 2021;17(1):78-84. doi: 10.2174/1573403X15666190509084519.
8
Cirrhotic cardiomyopathy.肝硬化性心肌病
Tunis Med. 2020 Mar;98(3):206-210.
9
Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.根据不同标准诊断的肝硬化心肌病对等待肝移植的肝硬化患者的影响:一项回顾性队列研究。
Dig Dis Sci. 2022 Nov;67(11):5315-5326. doi: 10.1007/s10620-022-07412-z. Epub 2022 Feb 12.
10
[Cirrhotic cardiomyopathy].[肝硬化性心肌病]
Dtsch Med Wochenschr. 2021 Aug;146(16):1070-1076. doi: 10.1055/a-1321-9523. Epub 2021 Aug 20.

引用本文的文献

1
The Value of Myocardial Energy Expenditure in the Diagnosis of Cirrhotic Cardiomyopathy.心肌能量消耗在肝硬化性心肌病诊断中的价值
Int J Gen Med. 2025 Jul 5;18:3767-3774. doi: 10.2147/IDR.S522910. eCollection 2025.
2
[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 2: ECG, functional tests, images, biomarkers, screening for coronary heart disease and differentianting diagnosis].[肝硬化性心肌病——临床事实还是学术好奇?综述。第2部分:心电图、功能测试、影像学、生物标志物、冠心病筛查及鉴别诊断]
Rev Fac Cien Med Univ Nac Cordoba. 2024 Jun 28;81(2):432-452. doi: 10.31053/1853.0605.v81.n2.44419.
3
Cardiomyopathy in cirrhosis: From pathophysiology to clinical care.
肝硬化中的心肌病:从病理生理学到临床护理
JHEP Rep. 2023 Sep 23;6(1):100911. doi: 10.1016/j.jhepr.2023.100911. eCollection 2024 Jan.
4
Cardiac risk stratification of the liver transplant candidate: A comprehensive review.肝移植候选者的心脏风险分层:一项全面综述。
World J Transplant. 2022 Jul 18;12(7):142-156. doi: 10.5500/wjt.v12.i7.142.
5
What's New in Cirrhotic Cardiomyopathy?-Review Article.肝硬化性心肌病有哪些新进展?-综述文章。
J Pers Med. 2021 Dec 3;11(12):1285. doi: 10.3390/jpm11121285.